Scholarlink

<p>Vessels encapsulating tumor clusters (VETC) represent a distinct vascular pattern that promotes metastasis via a mechanism independent of epithelial-mesenchymal transition (EMT), offering novel perspectives on metastasis research. Defined by sinusoid-like endothelial networks that enclose cohesive tumor cell aggregates, VETC enables collective hematogenous spread while preserving intercellular adhesion. Here, we reviewed the pathophysiological significance of VETC across solid tumors, with particular emphasis on hepatocellular carcinoma (HCC). Epidemiological data reveal that VETC prevalence varies significantly with tumor stage, etiology, and diagnostic criteria, and is strongly associated with aggressive features including microvascular invasion, multinodularity and immune exclusion. Mechanistically, VETC formation is driven by an angiopoietin-2 (Ang2)-centric network, involving crosstalk between the microRNA (miRNA)–androgen receptor (AR) pathway and tumor-associated macrophage-mediated vascular remodeling. Emerging therapeutic strategies, such as Ang2 inhibition combined with immune checkpoint blockade, vascular normalization, and complementary medicine, show promise in preclinical models. Clinically, VETC is an independent prognostic biomarker, offering greater predictive accuracy for recurrence than conventional staging systems. Despite this progress, challenges remain in standardizing diagnostic criteria, resolving spatiotemporal heterogeneity, and translating mechanistic insights into effective combination therapies. VETC defines a new paradigm at the intersection of vascular biology, immune evasion, and collective metastasis, with significant implications for precision oncology.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Vessels encapsulating tumor clusters in hepatocellular carcinoma: a distinct metastatic pathway with diagnostic and therapeutic significance

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月19日

查看全文
  • Yongfu Zhu,
  • Menglei Wang,
  • Jian Cao,
  • Hang song,
  • Pengcheng Zhang

摘要

Vessels encapsulating tumor clusters (VETC) represent a distinct vascular pattern that promotes metastasis via a mechanism independent of epithelial-mesenchymal transition (EMT), offering novel perspectives on metastasis research. Defined by sinusoid-like endothelial networks that enclose cohesive tumor cell aggregates, VETC enables collective hematogenous spread while preserving intercellular adhesion. Here, we reviewed the pathophysiological significance of VETC across solid tumors, with particular emphasis on hepatocellular carcinoma (HCC). Epidemiological data reveal that VETC prevalence varies significantly with tumor stage, etiology, and diagnostic criteria, and is strongly associated with aggressive features including microvascular invasion, multinodularity and immune exclusion. Mechanistically, VETC formation is driven by an angiopoietin-2 (Ang2)-centric network, involving crosstalk between the microRNA (miRNA)–androgen receptor (AR) pathway and tumor-associated macrophage-mediated vascular remodeling. Emerging therapeutic strategies, such as Ang2 inhibition combined with immune checkpoint blockade, vascular normalization, and complementary medicine, show promise in preclinical models. Clinically, VETC is an independent prognostic biomarker, offering greater predictive accuracy for recurrence than conventional staging systems. Despite this progress, challenges remain in standardizing diagnostic criteria, resolving spatiotemporal heterogeneity, and translating mechanistic insights into effective combination therapies. VETC defines a new paradigm at the intersection of vascular biology, immune evasion, and collective metastasis, with significant implications for precision oncology.